FDA Approves Expanded Age Indication for GARDASIL® 9 in Males
Go back to FDA Approves Expanded Age Indication for GARDASIL® 9 in Males| Merck & Co. (NYSE: MRK) | Delayed: 148.69 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.69 | 52 Week High | $65.46 | |||
| Open | $148.69 | 52 Week Low | $47.97 | |||
| Day High | $148.69 | P/E | 101.15 | |||
| Day Low | $148.69 | EPS | $1.47 | |||
| Volume | 2,446 | |||||
